Fig. 2From: Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptakeUptake of [3H]serotonin and [125I]MIBG in SERT- and NET-transfected HEK293 cells. a, b Results of Western blotting analysis on samples of transfected HEK cells. a Primary antibody against human SERT. b Primary antibody against human NET. c Uptake of [3H]serotonin by HEK-SERT cells. d Uptake of [125I]MIBG by HEK-SERT cells. e Uptake of [125I]MIBG by HEK-NET cells. Closed symbols (■, ●, ▲) represent baseline-corrected, transporter-specific uptake. Open symbols (□, ○, Δ) represent non-specific cellular uptake observed in HEK-Mock cells. Cells were incubated with substrate for 1 h. The Michaelis-Menten graph is depicted as a black dashed line. f The kinetic parameters from this analysis: Vmax in μmol/mg protein/min; Km in μM; catalytic efficiency: ratio \( \frac{V_{\mathrm{max}}}{K_m} \). Data represent mean ± SD (n = 2)Back to article page